CagriSema

Novo Mike Doustdar 2
Pharma

Novo struggles to appease restless investors with new strategy

CEO Mike Doustdar acknowledged that the company’s leadership “have to convince” investors that “there is a bright future for Novo.”
Karsten Munk Knudsen Novo Nordisk
Favicon Fierce Biotech

Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth

Aug 7, 2026 9:08am
Pharma money pharma money pharma profits Big Pharma sales drug sales

Obesity meds, China drive $2T in projected 2032 drug sales: report

Jun 23, 2026 9:00am
Mike Doustdar Novo Nordisk Novo Novo CEO

Novo Nordisk’s ‘optimistic’ CEO Doustdar sits down with Fierce

Jun 11, 2026 7:00am